Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel MSE Score to Predict the Postoperative Prognosis of Patients With Ruptured Hepatocellular Carcinoma

NCT05450874 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT05450874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05450874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel MSE Score to Predict the Postoperative Prognosis of Patients With Ruptured Hepatocellular Carcinoma
Lead sponsor
Tongji Hospital
Phase
Observational
Overall status
Completed
Start date
February 1, 2010
Completion date
June 1, 2022
Enrollment
300 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hcc